Simplifying Global Compliance
FDAnews Device Daily Bulletin
GI Dynamics Gets FDA Conditional OK for a Trial of its EndoBarrier Obesity Treatment
Aug. 24, 2012
GI Dynamics announced it has received conditional approval from the FDA to start a pivotal clinical trial of its EndoBarrier device for the treatment of patients who have uncontrolled Type 2 diabetes and who are obese.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing